Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01511666
Other study ID # Prague OHCA study
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 2013
Est. completion date October 25, 2020

Study information

Verified date March 2021
Source Charles University, Czech Republic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prague out-of Hospital Cardiac Arrest (OHCA) study is a prospective randomized multicenter clinical study comparing use of prehospital intraarrest hypothermia, mechanical chest compression device, extracorporeal life support (ECLS) and early invasive investigation and treatment (coronary angiography/percutaneous coronary intervention [PCI]; pulmonary angiography/percutaneous embolectomy; aortography) in all patients with OHCA of presumed cardiac origin compared to standard of care. It is hypothesized, that above stated "hyperinvasive" approach might improve outcome of out-of hospital cardiac arrest victims.


Description:

Background: Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent non-randomized study of ECLS (extracorporeal life support) in OHCA suggested further prospective multicenter studies to define population with OHCA that would benefit from ECLS. Aim: to perform a prospective randomized multicenter clinical study comparing use of prehospital intraarrest hypothermia, mechanical chest compression device, ECLS and early invasive investigation and treatment (coronary angiography/percutaneous coronary intervention [PCI]; pulmonary angiography/percutaneous embolectomy; aortography) in all patients with OHCA of presumed cardiac origin compared to standard of care. Planned intervention: patients with witnessed OHCA without ROSC (return of spontaneous circulation) after a minimum of 5 minutes of ACLS by emergency medical service (EMS) team will be after fulfilling of inclusion/exclusion criteria for the study randomized in a 1:1 design to standard vs. hyperinvasive arm. Patients in standard arm will be further managed as per recent guidelines. In hyperinvasive arm, mechanical compression device together with intranasal cooling will be immediately instituted and patients will be transferred to cardiac center directly to cathlab under ongoing CPR. After admission to cathlab, overall status, ROSC and ECLS inclusion/exclusion criteria will be evaluated and in case of no contraindications to ECLS and no ROSC or ROSC with shock, veno-arterial ECLS will be started as soon as possible, not later than 60 minutes after cardiac arrest onset. After ECLS institution, mild hypothermia will be continued by means of ECLS cooling and immediate invasive investigation will be performed in all patients. Standard postresuscitation care will follow.


Recruitment information / eligibility

Status Terminated
Enrollment 256
Est. completion date October 25, 2020
Est. primary completion date October 25, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - minimum of 18 and maximum of 65 years - witnessed out-of-hospital cardiac arrest of presumed cardiac cause - minimum of 5 minutes of ACLS performed by emergency medical service team without sustained ROSC - unconsciousness (Glasgow Coma Score < 8) - ECMO team and bed-capacity in cardiac center available. Exclusion Criteria: - OHCA of presumed non-cardiac cause - unwitnessed collapse - pregnancy - sustained ROSC within 5 minutes of ACLS performed by EMS team - conscious patient - known bleeding diathesis or suspected or confirmed acute or recent intracranial bleeding - suspected or confirmed acute stroke - known severe chronic organ dysfunction or other limitations in therapy - "do not resuscitate" order or other circumstances making 180 day survival unlikely - known pre-arrest cerebral performance category CPC = 3.

Study Design


Intervention

Device:
Prehospital mechanical compressions, intraarrest cooling and in hospital ECLS
ECLS states for extracorporeal life support.
Other:
Standard care
Standard care as per recent guidelines will be provided.

Locations

Country Name City State
Czechia General Teaching Hospital Prague

Sponsors (1)

Lead Sponsor Collaborator
Charles University, Czech Republic

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Composite endpoint of survival with good neurological outcome (CPC 1-2). 6 months
Secondary Neurological recovery Neurological recovery will be defined as no or minimal neurological impairment (CPC 1 or 2) at any timepoint within first 30 days after initial cardiac arrest. 30 days
Secondary Cardiac recovery Cardiac recovery will be assessed by the clinical status of hemodynamic stability defined as no need for pharmacological or mechanical cardiac support. Systolic function will be measured by echocardiography . 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT02850237 - Pre-Hospital Cerebral Oxygenation and End-Tidal CO2 During Cardiopulmonary Resuscitation (CPR) N/A